EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
This Quarter Return
-1.24%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.05B
AUM Growth
+$5.05B
(+0.56%)
Cap. Flow
+$230M
Cap. Flow
% of AUM
4.55%
Top 10 Holdings %
Top 10 Hldgs %
19.52%
Holding
911
New
26
Increased
159
Reduced
109
Closed
21
Top Buys
| 1 |
NVIDIA
NVDA
|
$72.1M |
| 2 |
Victoria's Secret
VSCO
|
$33.2M |
| 3 |
Moderna
MRNA
|
$22.6M |
| 4 |
Marsh & McLennan
MMC
|
$19.8M |
| 5 |
Automatic Data Processing
ADP
|
$19.3M |
Top Sells
| 1 |
Oracle
ORCL
|
$19.8M |
| 2 |
Ametek
AME
|
$13.5M |
| 3 |
NextEra Energy, Inc.
NEE
|
$12.7M |
| 4 |
Signet Jewelers
SIG
|
$11.8M |
| 5 |
Union Pacific
UNP
|
$11.2M |
Sector Composition
| 1 | Technology | 29.95% |
| 2 | Healthcare | 19.46% |
| 3 | Consumer Discretionary | 14.06% |
| 4 | Financials | 9.64% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $185M | 3.66% | 651,465 +26,906 | +4% | +$7.63M |
|
2
Apple
AAPL
$3.45T
| $155M | 3.08% | 1,089,290 +69,438 | +7% | +$9.9M |
|
3
Alphabet (Google) Class A
GOOGL
$2.57T
| $124M | 2.46% | 46,229 +5,044 | +12% | +$13.6M |
|
|
4
NVIDIA
NVDA
$4.24T
| $91.8M | 1.82% | 446,680 +351,142 | +368% | +$72.1M |
|
5
Adobe
ADBE
$151B
| $87.5M | 1.73% | 151,548 -2,303 | -1% | -$1.33M |
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $78.8M | 1.56% | 853,060 +30,000 | +4% | +$2.77M |
|
7
Visa
V
$683B
| $71.1M | 1.41% | 314,895 +21,453 | +7% | +$4.84M |
|
8
Biogen
BIIB
$19.4B
| $66.3M | 1.31% | 233,650 +11,315 | +5% | +$3.21M |
|
9
Silicon Motion
SIMO
$2.71B
| $64.8M | 1.28% | 939,000 -75,000 | -7% | -$5.17M |
|
10
Intuit
INTU
$186B
| $60.9M | 1.21% | 111,698 +14,488 | +15% | +$7.9M |
|
11
Starbucks
SBUX
$100B
| $56.7M | 1.12% | 511,924 +17,830 | +4% | +$1.98M |
|
12
PayPal
PYPL
$67.1B
| $54.9M | 1.09% | 211,403 +6,874 | +3% | +$1.78M |
|
13
Agios Pharmaceuticals
AGIO
$2.19B
| $52.8M | 1.04% | 1,143,200 +59,300 | +5% | +$2.74M |
|
14
Bristol-Myers Squibb
BMY
$96B
| $52.2M | 1.03% | 878,983 +29,233 | +3% | +$1.74M |
|
15
UnitedHealth
UNH
$281B
| $51.9M | 1.03% | 130,509 +3,026 | +2% | +$1.2M |
|
16
Mastercard
MA
$538B
| $51.1M | 1.01% | 144,781 +24,662 | +21% | +$8.7M |
|
17
Texas Roadhouse
TXRH
$11.5B
| $50.8M | 1.01% | 555,755 +35,000 | +7% | +$3.2M |
|
18
JPMorgan Chase
JPM
$829B
| $48M | 0.95% | 289,486 -3,040 | -1% | -$504K |
|
19
LKQ Corp
LKQ
$8.39B
| $47.5M | 0.94% | 943,800 | – | – |
|
20
Sabre
SABR
$706M
| $47.4M | 0.94% | 4,000,000 | – | – |
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $47M | 0.93% | 608,300 +3,400 | +0.6% | +$263K |
|
22
Thermo Fisher Scientific
TMO
$186B
| $46.4M | 0.92% | 80,174 -4,800 | -6% | -$2.78M |
|
23
Darling Ingredients
DAR
$5.37B
| $45.9M | 0.91% | 630,003 +67,812 | +12% | +$4.94M |
|
24
Xylem
XYL
$34.5B
| $44.5M | 0.88% | 347,896 +1,420 | +0.4% | +$182K |
|
25
Tapestry
TPR
$21.2B
| $44.5M | 0.88% | 1,200,800 | – | – |
|